Alyeska Investment Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-49,683
Closed -$2.45M – 502
2020
Q2
$2.45M Sell
49,683
-114,939
-70% -$6.2M 0.04% 343
2020
Q1
$8.39M Buy
164,622
+4,405
+3% +$254K 0.17% 142
2019
Q4
$8.83M Buy
160,217
+18,173
+13% +$986K 0.12% 179
2019
Q3
$7.15M Buy
+142,044
New +$7.14M 0.1% 187
2019
Q1
– Sell
-39,504
Closed -$1.94M – 400
2018
Q4
$1.94M Sell
39,504
-4,615
-10% -$262K 0.03% 287
2018
Q3
$2.74M Buy
+44,119
New +$2.68M 0.03% 280

Other funds holding EHC

Alyeska Investment Group's EHC Position: Q3 2020 in Review

Alyeska Investment Group sold out of Encompass Health (EHC) in Q3 2020, closing a stake of 49,683 shares — an estimated $2.45M sold.

Alyeska Investment Group first reported a position in EHC in Q3 2018 and held it in 6 quarters. The position peaked at $8.83M in Q4 2019. 380 funds tracked by Wall St. Rank hold EHC as of Q3 2020.

  • Alyeska Investment Group reported no remaining Encompass Health position as of Q3 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 49,683 Encompass Health shares in Q3 2020, an estimated $2.45M.
  • Alyeska Investment Group first reported a position in Encompass Health in Q3 2018 and held it in 6 quarters.
  • Alyeska Investment Group's Encompass Health position peaked at $8.83M in Q4 2019.
  • 380 funds tracked by Wall St. Rank held Encompass Health as of Q3 2020.

Based on Alyeska Investment Group's 13F filing for Q3 2020, filed 16 Nov 2020.